<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01632085</url>
  </required_header>
  <id_info>
    <org_study_id>5131</org_study_id>
    <secondary_id>2011-A01548-33</secondary_id>
    <nct_id>NCT01632085</nct_id>
  </id_info>
  <brief_title>Comparison of Two Laryngoscopes: Single-use Device Laryngobloc ® (SU) Versus Reusable Handle With Disposable Metal Blade (R)</brief_title>
  <acronym>MUUR</acronym>
  <official_title>Comparison of Two Laryngoscopes: Single-use Device Laryngobloc ® (SU) Versus Reusable Handle With Disposable Metal Blade (R) : Quality of Laryngoscopy and Bacterial Contamination of the Handle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reduce the risk of nosocomial transmission of germs related to the reusability of the
      laryngoscope handle. The alternative is to replace it with a disposable device, provided that
      it is as effective as the reference strategy at a reasonable cost.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The quality of laryngoscopy</measure>
    <time_frame>1 year</time_frame>
    <description>The quality of laryngoscopy. The quality of the visibility of the glottis, is assessed by the Cormack and Lehane grade. A rank of 1 or 2 will be considered a success for the analysis of results.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation microbiological and evaluation of intubation</measure>
    <time_frame>1 year</time_frame>
    <description>Evaluation microbiological (bacteria, fungi) and identification of bacteria with smears of the handle of laryngoscopes, the Laryngobloc ® and the reusable battery.
Evaluation of intubation: IDS score, satisfaction of the anesthesiologist, intubation time, quality of light offered by the device.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">480</enrollment>
  <condition>Contamination of the Handles</condition>
  <condition>Quality of the Laryngoscopy</condition>
  <arm_group>
    <arm_group_label>Group SU (Single use or Laryngobloc ®) ®)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In order to avoid an order effect, the patient acting as his own control, will randomly undergo a laryngoscopy with each laryngoscopes, the intubation being performed during the second laryngoscopy, here with the Laryngobloc ®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group R (Reusable handle)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In order to avoid an order effect, the patient acting as his own control, will randomly undergo a laryngoscopy with each laryngoscopes, the intubation being performed during the second laryngoscopy, here with the Disposable Metal Blade.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The two groups SU and R are defined by the device with which intubation is performed after a first laryngoscopy done with the other device.</intervention_name>
    <description>Group SU (Single Use or Laryngobloc ®): the first laryngoscopy is performed with the R and the second laryngoscopy and the intubation is performed with the Laryngobloc ®.
Group R (Reusable handle+ disposable metal blade): the first laryngoscopy is performed with the Laryngobloc ® and the second laryngoscopy and the intubation is performed with the R.</description>
    <arm_group_label>Group SU (Single use or Laryngobloc ®) ®)</arm_group_label>
    <arm_group_label>Group R (Reusable handle)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women over 18 years·

          -  Hospitalized for elective surgery and targeted for orotracheal intubation under direct
             laryngoscopy under general anesthesia with neuromuscular blockade resolved·

          -  Subject has signed informed consent·

          -  Suject affiliated to a social protection·

          -  Subject informed of the results of medical examination

        Exclusion Criteria:

          -  Contraindication to general anesthesia or one of its components·

          -  General anesthesia without a competitive muscle relaxant·

          -  Patient with criteria for difficult intubation·

          -  Patient targeted for special care of the airway (fiberoptic or vidéolaryngoscopy),
             whatever the indication as Mallampati class 4·

          -  Subject in class 4 Mallampati·

          -  Acts performed in the emergency setting·

          -  Pregnancy and obstetric procedures·

          -  Breastfeeding·

          -  Difficulty in communication with the patient (including obtaining informed consent,
             evaluation of pain in the recovery Room ·

          -  Subject in exclusion period (determined by a previous study or a study in progress)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre DIEMUNSCH, Pr</last_name>
    <phone>03 88 12 70 76</phone>
    <email>pierre.diemunsch@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg cedex</city>
        <state>Alsace</state>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Simone MANGEANT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nadia DHIF, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florin DIMACHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie STOJEBA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alice ILIE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine LEHMANN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriana NASTASIE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2012</study_first_submitted>
  <study_first_submitted_qc>June 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2012</study_first_posted>
  <last_update_submitted>June 28, 2012</last_update_submitted>
  <last_update_submitted_qc>June 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

